Legal Opinion
Eli Lilly and Company v. Hospira, Inc.
Court of Appeals for the Federal Circuit
Decided August 9, 2019No. 2018-2126; 2018-2127; 2018-2128PublishedCited by 45 opinions
1Opinion of the Court
Lourie, Circuit Judge.
Hospira Inc. ("Hospira"), Dr. Reddy's Laboratories Ltd., and Dr. Reddy's Laboratories Inc. (collectively, "DRL") appeal from two judgments of the United States District Court for the Southern District of Indiana in two infringement suits brought by Eli Lilly & Company ("Lilly") under the Hatch-Waxman Act, 21 U.S.C. § 355 . The district court held in each case that the defendant's submission of a New Drug Application pursuant to 21 U.S.C. § 355 (b)(2) infringed U.S. Patent 7,772,209 (the "'209 patent") under 35 U.S.C. § 271 (e)(2). See Eli Lilly & Co. v. Hospira, Inc. ,…
2Cases cited54 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- Heckler v. Community Health Services of Crawford County, Inc.Supreme Court of the United States · 1984
- Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.Supreme Court of the United States · 2002
49 more not listed; retrieve them via the Exa API.
3Cited by45 opinions
- Federal Trade Commission v. AbbVie IncCourt of Appeals for the Third Circuit · 2020
- McRo, Inc. v. Bandai Namco Games AmericaCourt of Appeals for the Federal Circuit · 2020
- Vlsi Technology LLC v. Intel CorporationCourt of Appeals for the Federal Circuit · 2023
- Pharma Tech Solutions, Inc. v. Lifescan, Inc.Court of Appeals for the Federal Circuit · 2019
- United Therapeutics Corporation v. Liquidia Technologies, Inc.Court of Appeals for the Federal Circuit · 2023
40 more not listed; retrieve them via the Exa API.